Korea's Botox boom fuels battle over technology restrictions

What happened: South Korea's botulinum toxin industry is split over whether to lift government protection on its manufacturing technology, which is designated a national Why it matters: Supporters say the restrictions delay licensing agreements, joint ventures, technology transfers and overseas manufacturing projects. Opponents say the designation provides a legal framework against unauthorized overseas transfers of protected strains and manufacturing technology. The Ministry of Trade, Industry and Energy is reviewing 79 designated national core technologies, with no final date announced.

South Korea's botulinum toxin industry is split over whether to lift government protection on its manufacturing technology, which is designated a national

Supporters say the restrictions delay licensing agreements, joint ventures, technology transfers and overseas manufacturing projects. Opponents say the designation provides a legal framework against unauthorized overseas transfers of protected strains and manufacturing technology. The Ministry of Trade, Industry and Energy is reviewing 79 designated national core technologies, with no final date announced.